|THE WORLD OF CIPLA
There’ll always be a healthier way to live, a warmer way
to care, a surer way to heal, a calmer way to sleep. There’ll
always be a better world, for those who have the passion
to create it. That’s been Cipla’s belief since 1935, when
we began as a small Indian enterprise committed to the
nation’s quest for self-sufficiency. The War that followed
saw Cipla rise to the challenge of meeting the alarming
shortage of essential medicines.
And by the 1960’s Cipla pioneered Bulk Drug manufacturing
in the country, which truly laid the foundation for the
Pharmaceutical industry in India. Over the years our
commitment to heal, protect and enrich lives has only
grown, and so have our capabilities.
Today we have 31 world-class manufacturing facilities spread across the country,
with dedicated plants for Oncology products, Hormones,
Inhalers, Carbapenems, and Cephlosporins, among others.
They more than meet the stringent international standards,
such as that of US FDA, MHRA–UK, TGA Australia, BFarm–Germany
MCC–South Africa, WHO, TPD- Canada.
Our API manufacturing plants are today among the most sophisticated in the world,
capable of complex multi-stage syntheses, and produce over
120 API’s from high potency actives in grams to those made
in several tonnes.
Cipla produces one of the widest range of products and dosage forms in the world
today, everything from metered-dose inhalers, pre-filled
syringes, trans-dermal spray patches, lyophilized injections,
nasal sprays, medical devices, and thermolabile foams.
Whether it is constantly extending our product range or
consistently introducing innovations, the mission is always
to make the life of the patient better.
CIPLA RESEARCH & DEVELOPMENT
skills are among the best in the world, what makes us different
is our multi-disciplinary approach to research.
Our research capabilities are
extensive, from Chemical Synthesis, Delivery Systems and
Medical Devices to Process Engineering, Animal Health Products,
Neutraceuticals and Biotechnology.
We believe there’s no use in developing
life-saving medicines if we can’t make them affordable
for the patient.
Today, across 170 countries, there
are millions of patients who get to use a Cipla product
to prevent, to cure, or for relief from suffering. In their
cure and relief lies the ultimate purpose of what we do.
At Cipla, this has been the driving
force behind our continuous quest for quality. And quality
is an obsession here for the 7000 people who walk into
work every morning.
World-class quality is reflected
in everything we do – from start to finish.
You’ll see concern for the environment
in our manufacturing processes, air and water systems,
safety practices, and above all, in our people.
We strive not just to meet international
specifications, but to exceed, to excel, to meet what we
call the Cipla benchmark. In fact, we have set standards
for the world to follow and have contributed to more than
125 monographs in the last 15 years - to British, European,
US and international pharmacopoeia.
Today companies from around the
world seek strategic alliances with Cipla for product development,
technical support and marketing. In a small way, we even
help countries set up their pharmaceutical infrastructure
and train their professionals, contributing to their quest
for self-reliance just the way we began healing India,
seven decades ago.
Over the years, we have taken on the challenges facing the world, tackling the
newer dimensions of diseases, like AIDS. At a time when
it was a death sentence and medication was unaffordable
to most, Cipla opened the doors of hope to millions and
millions of patients by becoming the first company in the
world to offer the Triple-Drug AIDS Cocktail for less than
a dollar a day. One out of every three HIV-AIDS patients
under treatment in Africa uses a Cipla drug.
Equally inspiring has been Cipla’s
fight against asthma. We partnered with the medical fraternity
to shatter myths, spread awareness and empowered asthma
patients to lead a fuller life. We have the world’s largest
range of asthma medication and delivery systems. This relentless
commitment to asthma inspired us to set up the Chest Research
Foundation. It’s one of the few Institutes in the world
that’s dedicated to clinical and allied research in the
field of Chronic Respiratory Diseases.
be patients who are beyond cure, they should be never beyond
care. The Cancer Palliative Care Centre for the terminally
ill is Cipla’s labour of love for the patients and their
families. A training institute for the medical community,
arising from a belief that if we can’t heal their disease,
we must try and heal their pain.
with a vision to build a healthy India. And along the way
realised, that in our own small way, we could contribute
to making the world a healthier place. We’ll continue to
bring a smile on as many faces as we can to heal the world
as much as we can.
Because there’ll always be a better world out there for those
who have the passion to create it.
At Cipla we enjoy challenges
and creating change for the better – for patients and
doctors, and for our own people. Some of our most successful
managers are in their 20s and 30s, and still rising because
they work with energy and passion. If you are looking
for a mission for life, look up our Careers section